Exane Derivatives’s IBM IBM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $2.29M | Sell |
16,200
-5,413
| -25% | -$731K | 1.31% | 13 |
|
|
2022
Q1 | $2.81M | Sell |
21,613
-2,189
| -9% | -$285K | 0.79% | 17 |
|
|
2021
Q4 | $3.18M | Buy |
23,802
+15,040
| +172% | +$1.89M | 0.77% | 19 |
|
|
2021
Q3 | $1.16M | Sell |
8,762
-1,911
| -18% | -$255K | 0.28% | 73 |
|
|
2021
Q2 | $1.43M | Sell |
10,673
-724
| -6% | -$99K | 0.32% | 65 |
|
|
2021
Q1 | $1.45M | Sell |
11,397
-1,062
| -9% | -$127K | 0.42% | 53 |
|
|
2020
Q4 | $1.5M | Sell |
12,459
-2,109
| -14% | -$244K | 0.44% | 44 |
|
|
2020
Q3 | $1.69M | Sell |
14,568
-1,518
| -9% | -$179K | 0.49% | 41 |
|
|
2020
Q2 | $1.86M | Sell |
16,086
-26,009
| -62% | -$3.02M | 0.5% | 64 |
|
|
2020
Q1 | $4.46M | Sell |
42,095
-26,810
| -39% | -$3.39M | 1.25% | 20 |
|
|
2019
Q4 | $9M | Buy |
+68,905
| New | +$8.96M | 1.67% | 8 |
|
|
2019
Q3 | – | Sell |
-26,301
| Closed | -$3.47M | – | 673 |
|
|
2019
Q2 | $3.47M | Sell |
26,301
-13,353
| -34% | -$1.75M | 0.61% | 51 |
|
|
2019
Q1 | $5.35M | Buy |
39,654
+27,203
| +218% | +$3.47M | 1.06% | 17 |
|
|
2018
Q4 | $1.35M | Sell |
12,451
-9,473
| -43% | -$1.14M | 0.24% | 98 |
|
|
2018
Q3 | $3.17M | Sell |
21,924
-1,786
| -8% | -$250K | 0.59% | 44 |
|
|
2018
Q2 | $3.17M | Buy |
23,710
+2,797
| +13% | +$390K | 0.53% | 34 |
|
|
2018
Q1 | $3.05M | Buy |
20,913
+1,393
| +7% | +$211K | 0.61% | 30 |
|
|
2017
Q4 | $2.86M | Buy |
19,520
+11,088
| +131% | +$1.61M | 0.49% | 34 |
|
|
2017
Q3 | $1.17M | Sell |
8,432
-726
| -8% | -$101K | 0.22% | 78 |
|
|
2017
Q2 | $1.35M | Buy |
9,158
+520
| +6% | +$78.4K | 0.29% | 84 |
|
|
2017
Q1 | $1.44M | Sell |
8,638
-4,475
| -34% | -$750K | 0.33% | 71 |
|
|
2016
Q4 | $2.08M | Sell |
13,113
-1,340
| -9% | -$204K | 0.41% | 58 |
|
|
2016
Q3 | $2.19M | Buy |
14,453
+3,398
| +31% | +$516K | 0.33% | 61 |
|
|
2016
Q2 | $1.6M | Sell |
11,055
-822
| -7% | -$118K | 0.26% | 60 |
|
|
2016
Q1 | $1.72M | Sell |
11,877
-2,783
| -19% | -$355K | 0.23% | 63 |
|
|
2015
Q4 | $1.93M | Buy |
14,660
+8,764
| +149% | +$1.18M | 0.26% | 57 |
|
|
2015
Q3 | $817K | Buy |
5,896
+1,188
| +25% | +$175K | 0.1% | 100 |
|
|
2015
Q2 | $732K | Sell |
4,708
-1,341
| -22% | -$216K | 0.08% | 115 |
|
|
2015
Q1 | $928K | Buy |
6,049
+2,360
| +64% | +$358K | 0.1% | 100 |
|
|
2014
Q4 | $566K | Buy |
+3,689
| New | +$587K | 0.08% | 133 |
|
Other funds holding IBM
Exane Derivatives's IBM Position: Q2 2022 in Review
Exane Derivatives reduced its IBM (IBM) stake by 25% in Q2 2022, selling an estimated $731K and leaving 16,200 shares worth $2.29M. The position accounts for 1.31% of the portfolio, ranked #13.
Exane Derivatives first reported a position in IBM in Q4 2014 and has held it in 30 quarters since. The position peaked at $9M in Q4 2019. 2,376 funds tracked by Wall St. Rank hold IBM as of Q2 2022.
- Exane Derivatives held 16,200 shares of IBM worth $2.29M as of Q2 2022.
- Exane Derivatives sold 5,413 IBM shares in Q2 2022, an estimated $731K.
- IBM made up 1.31% of Exane Derivatives's portfolio in Q2 2022, its #13 holding.
- Exane Derivatives first reported a position in IBM in Q4 2014 and has held it in 30 quarters since.
- Exane Derivatives's IBM position peaked at $9M in Q4 2019.
- 2,376 funds tracked by Wall St. Rank held IBM as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.